Ultralife Corporation
ULBI
$6.86
$0.060.88%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -70.39% | -35.49% | -89.76% | -80.60% | -11.11% |
| Total Depreciation and Amortization | 39.57% | 39.98% | 22.05% | 0.71% | 2.94% |
| Total Amortization of Deferred Charges | 325.00% | 306.25% | 193.75% | -25.00% | 0.00% |
| Total Other Non-Cash Items | -47.03% | -29.00% | 48.21% | -80.04% | -35.63% |
| Change in Net Operating Assets | -22.97% | 89.50% | 182.05% | 192.04% | 199.13% |
| Cash from Operations | -33.50% | 4,258.02% | 25.25% | 633.86% | 409.71% |
| Capital Expenditure | -205.56% | -140.59% | 39.70% | -11.24% | 30.23% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -205.56% | -140.59% | -4,738.61% | -11.24% | 30.23% |
| Total Debt Issued | -- | -- | 5,400.00% | -- | -- |
| Total Debt Repaid | 79.60% | -37.40% | -435.67% | -706.60% | -2,535.80% |
| Issuance of Common Stock | -95.12% | -- | -81.16% | -97.55% | 1,917.74% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 77.77% | -471.35% | 15,276.08% | -267.85% | -863.64% |
| Foreign Exchange rate Adjustments | 182.61% | -11.24% | 87.92% | -25.00% | 61.34% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 165.18% | 1,141.90% | -91.81% | -91.75% | -227.30% |